Why the study?
RDW has been linked to early mortality through unknown mechanisms, and experimental animal model evidence regarding hypoxia increasing both RDW and mortality is lacking.
Do compound heterozygous knockout mutations in succinate dehydrogenase genes reduce high red cell distribution width and improve survival in chronically hypoxic mice?
Do compound heterozygous knockout mutations in succinate dehydrogenase genes reduce high red cell distribution width and improve survival in chronically hypoxic mice?
Answers are grounded in this paper and cite their sources.
Partial loss of succinate dehydrogenase reduces hypoxia-induced high red cell distribution width and improves survival in mice, suggesting SDH as a potential therapeutic target.
Increased red cell distribution width (RDW), which measures erythrocyte size variability (anisocytosis), has been linked to early mortality in many diseases and normal aged population through unknown mechanisms. Hypoxia has been proposed to increase both RDW and mortality. However, experimental evidence, especially in animal models, is lacking. Here, we show that chronic hypobaric hypoxia (~10% O 2 ) increases erythrocyte numbers, hemoglobin and RDW, while reducing longevity in male mice. Compound heterozygous knockout (chKO) mutations in succinate dehydrogenase (Sdh; mitochondrial complex II) genes Sdhb, Sdhc and Sdhd reduce high RDW and immature reticulocyte fraction, and increase healthy lifespan in chronic hypoxia. Hemoglobin and erythrocyte numbers in hypoxia do not show statistically significant differences between Sdh chKO and WT mice. These results identify a mitochondrial mechanism regulating both RDW and organismal adaptation to chronic hypoxia, and suggest SDH as a potential therapeutic target to reduce high RDW-associated clinical mortality.
No takes yet. Share an insight, caveat, or question.
Baysal et al. (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: